Mushrooms, Inc. is a development stage company, which acquires and builds a portfolio of cannabis markets. The company is headquartered in Estero, Florida. The company went IPO on 2006-11-17. The company is engaged in the biotechnology and sustainable healthcare solutions using mushrooms and mycelium. The firm is focused on the industrial application of mycelium for the creation of carbon-neutral products for the building and health care industries, as well as creating supplements based on the proven health benefits of mushrooms. Mycelium is a natural fiber that can be used as an alternative to plastics. Mycelium can be used in applications such as insulation, structural insulating panels, acoustical tiles, and building blocks. The company is improving the threads and fabrics in use with its antimicrobial, anti-MRSA, renewable and eco-positive threads and fabric solutions. The company also works together with scientists and medical supply innovators to implement this technology into the range of potential medical applications.
How did MSRM's recent EPS compare to expectations?
The most recent EPS for Mushrooms Inc is $, expectations of $.
How did Mushrooms Inc MSRM's revenue perform in the last quarter?
Mushrooms Inc revenue for the last quarter is $
What is the revenue estimate for Mushrooms Inc?
According to of Wall street analyst, the revenue estimate of Mushrooms Inc range from $ to $
What's the earning quality score for Mushrooms Inc?
Mushrooms Inc has a earning quality score of A-/58.11688. The score is based on a four dimension of Profitability, Growth, Cash generation & Capital Allocation, and Leverage.
When does Mushrooms Inc report earnings?
Mushrooms Inc next earnings report is expected in
What are Mushrooms Inc's expected earnings?
Mushrooms Inc expected earnings is $, according to wall-street analysts.